Company Overview of PeriCor Therapeutics, Inc.
PeriCor Therapeutics, Inc., a specialty biopharmaceutical company, develops and commercializes novel therapies to protect threatened heart muscle in surgical and acute settings. It develops adenosine regulating agents, which amplifies the body’s own protective response to ischemia, and reperfusion injury and tissue damage that occurs after interrupted blood flow is restored. PeriCor Therapeutics, Inc. was incorporated in 2004 and is based in New York, New York.
350 Fifth Avenue
New York, NY 10118
Founded in 2004
Key Executives for PeriCor Therapeutics, Inc.
Similar Private Companies By Industry
|MDS Analytical Technologies (US) Inc.||United States|
|MPC Corporation||United States|
|CalciMedica, Inc.||United States|
|Angiotech Pharmaceuticals (US), Inc.||United States|
|Minerva Biotechnologies Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- East Township, NY | AstraZenecaPosted: Dec 05
- San Francisco, CA | JobvertisePosted: Nov 30
- Parsippany, NJ | RGPPosted: Nov 27
Sponsored Financial Commentaries
To contact PeriCor Therapeutics, Inc., please visit www.pericortherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.